Economic activity accelerates heading into springBy RSM US LLP | May 4, 2021March was another strong month for risk assets, especially in the U.S. as vaccine manufacturing and distribution ramped up.Read more...
Optimism aboundsBy RSM US LLP | March 1, 2021While we are constructive on near-term markets, we will focus on the rebound in business activity following progress with the vaccine.Read more...